Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies-Reference-Cited by-同舟云学术

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies

Published:2019-10-16 Issue:2 Volume:179 Page:387-401
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Carene Dimitri,Tran-Dien Alicia,Lemonnier Jérôme,Dalenc Florence,Levy Christelle,Pierga Jean-Yves,Jacot William,Canon Jean-Luc,Richon Catherine,Lacroix Ludovic,Caux Christophe,André Fabrice,Michiels Stefan^ORCID

Funder

ANR

INCa

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05462-y.pdf

Reference26 articles.

1. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG et al (2014) US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju055

2. Cianfrocca M, Goldstein LJ (2004) Prognostic and predictive factors in early-stage breast cancer. Oncologist 9:606–616

3. Rugo HS (2008) The importance of distant metastases in hormone-sensitive breast cancer. Breast 17(Suppl 1):S3–S8

4. Rosano GMC (2007) The importance of distant metastasis and its impact on survival rates on early-stage hormone receptor-positive breast cancer. US Oncol Dis 1:22–25

5. Mohammadizadeh F, Hani M, Ranaee M, Bagheri M (2013) Role of cyclin D1 in breast carcinoma. J Res Med Sci 18:1021–1025

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Select gene mutations associated with survival outcomes in ER‐positive ERBB2‐negative early‐stage invasive breast cancer: A single‐institutional tissue bank study;Cancer Medicine;2024-07

2. Unveiling breast cancer risk profiles: a survival clustering analysis empowered by an online web application;Future Oncology;2023-12

3. Genetic and Immunohistochemical Profiling of Mammary Hidradenoma and Comparison to Mucoepidermoid Carcinoma;Modern Pathology;2023-10

4. Genomics to select treatment for patients with metastatic breast cancer;Nature;2022-09-07

5. Prognostic and Predictive Value of CCND1/Cyclin D1 Amplification in Breast Cancer With a Focus on Postmenopausal Patients: A Systematic Review and Meta-Analysis;Frontiers in Endocrinology;2022-06-17